Atlas Trials

Haihe Biopharma Co., Ltd.

19 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Haihe Biopharma Co., Ltd.

RecordFirmDate
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM) (NCT06975618)Haihe Biopharma Co., Ltd.2023-08-22
Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma (NCT06909877)Haihe Biopharma Co., Ltd.2022-07-27
A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma (NCT05043922)Haihe Biopharma Co., Ltd.2021-10-11
First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid Tumors (NCT04746612)Haihe Biopharma Co., Ltd.2021-04-08
Evaluate the Safety and Clinical Activity of HH2853 (NCT04390737)Haihe Biopharma Co., Ltd.2020-09-08
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors (NCT04198818)Haihe Biopharma Co., Ltd.2020-01-07
Glumetinib Combined With Osimertinib in the Treatment of Relapsed and Metastatic Non-small Cell Lung Cancer Patients Who Failed to Receive EGFR Inhibitors (NCT04338243)Haihe Biopharma Co., Ltd.2019-11-18
This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients (NCT04254471)Haihe Biopharma Co., Ltd.2019-11-14
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer (NCT04270591)Haihe Biopharma Co., Ltd.2019-07-15
Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33 (NCT03544905)Haihe Biopharma Co., Ltd.2018-07-05
A Phase I Study of SCC244 in Patients with Advanced MET Alterations Solid Tumors (NCT03457532)Haihe Biopharma Co., Ltd.2017-12-16
Study to Evaluate the Safety and Anti-tumor Activity of SCC244 (NCT03466268)Haihe Biopharma Co., Ltd.2017-09-14

Track Haihe Biopharma Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.